Human APLNR Full-Length Bioactive Membrane Protein (HDFP113)
- SKU:
- HDFP113
- Product Type:
- Recombinant Protein
- Protein Type:
- Full-Length Bioactive Membrane Protein
- Species:
- Human
- Uniprot:
- P35414
Frequently bought together:
Description
system_update_altDatasheet
| Product name | Human APLNR full length protein-synthetic nanodisc |
| Size: | 10ug |
| Product SKU: | HDFP113 |
| Product Category | Full Length Transmembrane Proteins |
| Target: | APLNR |
| Uniprot: | P35414 |
| Description: | Human APLNR full length protein-synthetic nanodisc |
| Molecular Weight: | The human full length APLNR protein has a MW of 42.7 kDa |
| Protein Family: | Druggable Genome, GPCR, Transmembrane |
| Protein Pathways: | Neuroactive ligand-receptor interaction |
| Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Synonyms: | AGTRL1; APJ; APJR; HG11 |
| Expression System: | HEK293 |
| Formulation: | Lyophilized from nanodisc solubilization buffer (20 mM Tris-HCl, 150 mM NaCl, pH 8.0). Normally 5% - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
| Background: | This gene encodes a member of the G protein-coupled receptor gene family. The encoded protein is related to the angiotensin receptor, but is actually an apelin receptor that inhibits adenylate cyclase activity and plays a counter-regulatory role against the pressure action of angiotensin II by exerting hypertensive effect. It functions in the cardiovascular and central nervous systems, in glucose metabolism, in embryonic and tumor angiogenesis and as a human immunodeficiency virus (HIV-1) coreceptor. Two transcript variants resulting from alternative splicing have been identified. [provided by RefSeq, Jul 2009] |
| Delivery: | 3-4 weeks |
| Usage | Research use only |
